Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing voglibose to acarbose in Type 2 Diabetes Mellitus assessed efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acarbose (acarbose)
  • Voglibose (voglibose)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-02-04